Институт за медицинска истраживања

Институт за медицинска истраживања Институт за медицинска истраживања - Универзитет у Београду
Институт од националног значаја

Hronični stres nije samo prateći faktor bolesti već biološki aktivan proces koji može dovesti do inflamacije uz promene ...
23/04/2026

Hronični stres nije samo prateći faktor bolesti već biološki aktivan proces koji može dovesti do inflamacije uz promene u ćelijskom okruženju i doprinos razvoju i progresiji malignih bolesti.

Dr Sanja Vignjević Petrinović govorila je o temi „Hronični i : inflamacija kao karika koja povezuje“, u okviru segmenta Stres i fizičko zdravlje na Forumu Институт за ментално здравље, održanom 17. aprila u Muzeju Jugoslovenske kinoteke.

Tokom predavanja, posebno je istakla značaj inflamacije, kao jednog od ključnih bioloških mehanizama u okviru biopsihosocijalnog modela stresa, koji razmatra međusobno povezane biološke, psihološke i socijalne dimenzije, i ukazuje na potrebu za integrisanijim pristupom razumevanju povezanosti stresa i bolesti.

//

Chronic stress is not merely an accompanying factor in disease, but a biologically active process that, through prolonged dysregulation of neuroendocrine and immune responses, can lead to persistent inflammation, alter the cellular environment, and contribute to the development and progression of malignancies.

Dr. Sanja Vignjević Petrinović spoke on the topic “Chronic and : Inflammation as the Connecting Link” within the Stress and Physical Health segment of the Forum of the Institute of Mental Health, held on 17 April at the Yugoslav Film Archive Museum.

The lecture highlighted the importance of inflammation as a key biological mechanism within the biopsychosocial model of stress, which understands stress through interconnected biological, psychological, and social dimensions and points to the need for a more integrated approach to understanding and addressing the relationship between stress and disease.

Koliko smo daleko od efikasnijeg tretmana toksoplazmoze?🧪 Novi   Naučni seminar donosi uvid u dizajn, sintezu i in vitro...
20/04/2026

Koliko smo daleko od efikasnijeg tretmana toksoplazmoze?

🧪 Novi Naučni seminar donosi uvid u dizajn, sintezu i in vitro evaluaciju N-(9-akridinil) derivata amino-kiselina kao potencijalnih agenasa protiv parazita Toxoplasma gondii 🦠 koji predstavlja ozbiljan rizik prvenstveno za imunokompromitovane pacijente i trudnice.

Predavanje će pokazati kako razlike u hemijskoj strukturi novih akridinskih derivata utiču na njihovu citotoksičnost i antiparazitsku aktivnost, uz poseban fokus na identifikaciju jedinjenja sa obećavajućim farmakološkim profilom.

🔜 Pridružite nam se ako vas zanima kako izgleda put od molekula do potencijalnog leka.

📅 24. april
🕛 11:00
📍 Biblioteka Instituta za medicinska istraživanja ili online putem Microsoft Teams platforme
✔️ Bez prethodne rezervacije

//

How far are we from a more effective treatment for toxoplasmosis?

🧪 The new Scientific Seminar offers insight into the design, synthesis, and in vitro evaluation of N-(9-acridinyl) amino acid derivatives as potential agents against Toxoplasma gondii 🦠, a parasite that poses a serious risk primarily to immunocompromised patients and pregnant women.

The talk will show how subtle differences in chemical structure shape cytotoxicity and antiparasitic activity, with a particular focus on identifying compounds with promising pharmacological profiles.

🔜 Join us if you’d like to see how a single molecule can evolve into a potential therapy.

📅 April 24
🕛 11:00 AM
📍 Institute for Medical Research Library or online via Microsoft Teams
✔️ No registration required

Imali smo priliku da na IMI-ju ugostimo prof. dr Gülşah Kaner Tohtak, rukovoditeljku Odeljenja za ishranu i dijetetiku F...
06/04/2026

Imali smo priliku da na IMI-ju ugostimo prof. dr Gülşah Kaner Tohtak, rukovoditeljku Odeljenja za ishranu i dijetetiku Fakulteta zdravstvenih nauka na İzmir Kâtip Çelebi Univerzitetu, u okviru Erasmus+ teaching mobilnosti.

Kao deo programa Naučnih seminara, prof. dr Kaner Tohtak govorila je o vezi između ishrane, inflamacije i hroničnog bola, uz osvrt na antiinflamatorne obrasce ishrane, uključujući mediteransku dijetu.

Tokom posete prezentovan je i FOODPATH Horizon Europe projekat, u kojem učestvuje kao nacionalna koordinatorka za Tursku, sa ciljem unapređenja politika zdravog prehrambenog okruženja.

Sa naše strane, predstavljeni su laboratorijski kapaciteti i istraživački pravci Grupe za nutritivnu biohemiju i dijetologiju, čime su dodatno osnažene mogućnosti za razmenu znanja i buduću saradnju.

//

We had the opportunity to host Dr. Gülşah Kaner Tohtak at IMR as part of the Erasmus+ teaching mobility program. Dr. Kaner Tohtak heads the Department of Nutrition and Dietetics at the Faculty of Health Sciences, İzmir Kâtip Çelebi University.

As part of our Scientific Seminars, she discussed the connection between diet, inflammation, and chronic pain, focusing on anti-inflammatory dietary patterns, including the Mediterranean diet.

During her visit, she also presented the FOODPATH Horizon Europe project, where she serves as the national coordinator for Turkey, working to improve policies that support healthier food environments.

On our side, we presented the laboratory capacities and research avenues of the Group for Nutritional Biochemistry and Dietology, supporting knowledge exchange and future collaboration.

Da li način na koji se hranimo može da utiče na to koliko osećamo bol?Na narednom   Naučnom seminaru, Dr Gülşah Kaner To...
18/03/2026

Da li način na koji se hranimo može da utiče na to koliko osećamo bol?
Na narednom Naučnom seminaru, Dr Gülşah Kaner Tohtak, šefica Odseka za ishranu i dijetetiku na Fakultetu zdravstvenih nauka Univerziteta İzmir Kâtip Çelebi, govoriće o vezi između inflamacije, hroničnog bola i nutritivnih faktora.

U fokusu predavanja:
👉🏻 Biološki mehanizmi bola povezanog sa upalom
👉🏻 Uloga sastava masti i omega-3 masnih kiselina u ishrani
👉🏻 Značaj unosa vlakana i mikronutrijenata (vitamin D, magnezijum)
👉🏻 Efekti obrazaca ishrane poput mediteranske i antiinflamatorne dijete na bol i upalne markere

Dođite na Seminar, biće prostora za pitanja, razmenu i nove uvide.

📅 25. mart
🕛 11:00
📍 Amfiteatar katedre za higijenu i tehnologiju mesa, Veterinarski fakultet ili online putem Microsoft Teams platforme
✔️ Bez prethodne rezervacije

//

Can what we eat shape how we experience pain?

At the upcoming Scientific Seminar, Dr. Gülşah Kaner Tohtak, Head of the Department for Nutrition and Dietetics at the Faculty of Health Sciences, İzmir Kâtip Çelebi University, will unpack the link between inflammation, chronic pain, and nutrition.

In focus:
👉🏻 Biological mechanisms of inflammation-related pain
👉🏻 The role of dietary fat composition and omega-3 fatty acids
👉🏻 The importance of fiber intake and key micronutrients (vitamin D, magnesium)
👉🏻 The impact of dietary patterns such as the Mediterranean and anti-inflammatory diets on pain and inflammatory markers

Join us for a chance to ask questions, share perspectives, and leave with fresh insights.

📅 March 25
🕛 11:00
📍 Amphitheatre, Department of Meat Hygiene and Technology, Faculty of Veterinary Medicine, University of Belgrade, or online via Microsoft Teams
✔️ No registration required

🔊 Kako izgledaju novi terapijski pravci u borbi protiv raka i hroničnog bola? O ovim temama govorimo na prvom ovogodišnj...
04/03/2026

🔊 Kako izgledaju novi terapijski pravci u borbi protiv raka i hroničnog bola? O ovim temama govorimo na prvom ovogodišnjem Naučnom seminaru uz dva gostujuća predavača sa Farmaceutskog fakulteta.

🗣️ Dr Milan Beljkaš predstaviće razvoj dualnih HDAC/ROCK inhibitora kao potencijalne terapijske strategije za agresivne malignitete, uključujući duktalni adenokarcinom pankreasa i trostruko-negativni karcinom dojke.

🗣️ Katarina Sićović govoriće o terapijskom potencijalu semaglutida u modelu hronične migrene sa fokusom na bolnu preosetljivost, kognitivne deficite i ulogu centralnih opioidergičkih mehanizama u farmakološkom odgovoru.

📅 12. mart
🕛 11:00
📍 Institut za medicinska istraživanja ili online putem Microsoft Teams platforme
✔️ Bez prethodne rezervacije
Vidimo se. 👋

//

🔊 What do new therapeutic directions in cancer and chronic pain research look like? We’ll explore these questions at the first Scientific Seminar of 2026, featuring two guest speakers from the Faculty of Pharmacy.

🗣️ Dr. Milan Beljkaš will present the development of dual HDAC/ROCK inhibitors as a potential therapeutic strategy for aggressive malignancies, including pancreatic ductal adenocarcinoma (PDAC) and triple-negative breast cancer (TNBC).

🗣️ Katarina Sićović will discuss the therapeutic potential of semaglutide in a model of chronic migraine, focusing on pain hypersensitivity, cognitive deficits, and the role of central opioidergic mechanisms in shaping the pharmacological response.

📅 March 12
🕛 11:00 AM
📍 Institute for Medical Research or online via Microsoft Office Teams platform
✔️ No registration required
See you there. 👋

Na radnom sastanku održanom u Institutu „Mihajlo Pupin“, sa direktorom dr Nikolom Tomaševićem i njegovim timom, razgovar...
27/02/2026

Na radnom sastanku održanom u Institutu „Mihajlo Pupin“, sa direktorom dr Nikolom Tomaševićem i njegovim timom, razgovarali smo o mogućnostima zajedničkog rada na evropskim projektima i razvoju istraživačkih inicijativa koje povezuju komplementarne naučne ekspertize.

Sastanku su, pored direktora IMI-ja, dr Saše Radovanovića, prisustvovale pomoćnica direktora za naučno-istraživački rad dr Snežana Tomanović i predstavnice istraživačkog tima Instituta.

Dijalog između institucija ostaje važan korak ka definisanju konkretnih modela saradnje i projektnih aktivnosti sa dugoročnim naučnim i društvenim efektima.

//

A working meeting at the “Mihajlo Pupin” Institute with Director Dr. Nikola Tomašević and his team provided an opportunity to explore joint engagement in European projects and discuss the development of research initiatives that bring together complementary scientific expertise.

Alongside IMR Director Dr. Saša Radovanović, the meeting was attended by the Assistant Director for Science and Research, Dr. Snežana Tomanović, and members of the Institute’s research team.

Continued dialogue between institutions allows us to define concrete collaboration models and joint project activities.

Dr Tijana Štajner je na panelu „Put žena u nauci: prepreke i motivacije“, održanom u Naučno-tehnološki park Beograd povo...
18/02/2026

Dr Tijana Štajner je na panelu „Put žena u nauci: prepreke i motivacije“, održanom u Naučno-tehnološki park Beograd povodom Međunarodnog dana žena i devojaka u nauci, podelila lično iskustvo o izazovima sa kojima se susretala tokom karijere.

Prema njenim rečima, upornost, jasna profesionalna vizija i mogućnost šireg društvenog uticaja motivisali su je da nastavi stručni razvoj u presudnim trenucima karijere. Govoreći iz perspektive dugogodišnjeg rada u istraživačkom sistemu, dr Štajner je istakla važnost izgradnje kompetencija, snažnih mreža podrške i institucionalnih mehanizama koji ženama otvaraju put ka liderskim pozicijama u nauci.

U Institutu za medicinska istraživanja duboko verujemo da dugoročno ulaganje u znanje, jasno definisane profesionalne putanje i vidljivost osnažuje položaj žena u nauci i predstavlja ključan faktor dugoročne naučne relevantnosti sa realnim uticajem.

//

Dr. Tijana Štajner spoke at the panel “Women’s Path in Science: Barriers and Motivations,” held at the Naučno-tehnološki park Beograd, in celebration of the International Day of Women and Girls in Science. She reflected on the challenges she had encountered throughout her career.

She pointed out that perseverance, a clear professional vision, and a focus on broader societal impact were what tipped the scales at decisive moments in her career. Speaking from long-term experience in the research system, Dr. Štajner emphasized that progress does not happen by chance. Building solid competencies, relying on strong support networks, and having institutional mechanisms in place are what allow women to step into leadership roles in science.

At the Institute for Medical Research, we hold that sustained investment in knowledge, transparent career pathways, and professional visibility strengthens the position of women in science and remains essential for long-term scientific relevance with real impact.

13/02/2026

👩‍🔬 Naše naučnice svakodnevno postavljaju pitanja, traže odgovore i ne pristaju na manje od dokaza. Istraživačice sa -ja su se povodom Međunarodnog dana žena i devojaka u nauci okupile kako bi istakle doprinos onih koje su nekada bile nevidljive, a danas su nezaobilazne vizionarke i inovatorke koje ohrabruju dolazak novih generacija naučnica.

🎥 Video: Министарство науке, технолошког развоја и иновација

//

👩‍🔬 Our scientists ask questions. They follow the evidence. Never compromise.

On the International Day of Women and Girls in Science, researchers from came together to recognize women who were once invisible and are now essential innovators, opening the door for the next generation.

🎥 Video credit: Министарство науке, технолошког развоја и иновација

Dragana Aleksandrović iz Grupe za hematologiju i matične ćelije održala je dva predavanja na studentskoj konferenciji „S...
26/01/2026

Dragana Aleksandrović iz Grupe za hematologiju i matične ćelije održala je dva predavanja na studentskoj konferenciji „Studenti u susret nauci“ u Banja Luci od 27 do 29. novembra 2025.

Osim što je predstavila rezultate doktorskog istraživanja na predavanju pod nazivom “The Role of Ecto-5'-Nucleotidase (CD73) in Regeneration and Immunomodulation of Human Bone Marrow Mesenchymal Stem Cells", Dragana je govorila i o nalazima projekta AmnioPrintCare u okviru segmenta “Human Amniotic Membrane - Derived Biomaterials for Soft Tissue Engineering: Development of 3D-Bioprintable Scaffolds”.

//

At the student conference “Students Encountering Science”, held in Banja Luka on 27–29 November 2025, Dragana Aleksandrović from the Group for Hematology and Stem Cells delivered two inspiring talks.

In her first lecture, “The Role of Ecto-5'-Nucleotidase (CD73) in Regeneration and Immunomodulation of Human Bone Marrow Mesenchymal Stem Cells," she shared key insights from her PhD research. In the second, “Human Amniotic Membrane - Derived Biomaterials for Soft Tissue Engineering: Development of 3D-Bioprintable Scaffolds,” she presented results from the AmnioPrintCare project.

Dr Drenka Trivanović i dr Tamara Kukolj iz Grupe za hematologiju i matične ćelije učestvovale su na XXV kongresu Italija...
09/01/2026

Dr Drenka Trivanović i dr Tamara Kukolj iz Grupe za hematologiju i matične ćelije učestvovale su na XXV kongresu Italijanskog društva za osteoporozu, mineralni metabolizam i skeletne bolesti (SIOMMMS), od 13. do 15. decembra u Sijeni.

Tamara Kukolj je, kao postdoktorska istraživačica, predstavila najnovije rezultate svojih istraživanja na predavanju pod nazivom “N-azacytidine inhibits the growth of the myeloma cells, while preserving the osteogenic capacity of bone marrow stromal cells from multiple myeloma patients” u okviru SIOMMMS-IFMRS Fellow Day događaja.

Zahvaljujemo se organizatorima skupa, kao i Biagio Palmisano na gostoprimstvu i podršci tokom boravka.

//

Dr. Drenka Trivanović and Dr. Tamara Kukolj from the Group for Hematology and Stem Cells participated in the XXV Congress of the Italian Society for Osteoporosis, Mineral Metabolism, and Skeletal Diseases (SIOMMMS), held in Siena from December 13-15.

As a postdoctoral researcher, Tamara Kukolj presented her latest findings in a lecture entitled “N-azacytidine inhibits the growth of myeloma cells, while preserving the osteogenic capacity of bone marrow stromal cells from multiple myeloma patients”, delivered within the SIOMMMS–IFMRS (International Federation of Musculoskeletal Research Societies) Fellow Day program.

We thank the conference organizers, and in particular Biagio Palmisano, for the warm hospitality and support throughout the stay.

26/12/2025

Na nedavno održanom Forumu -ja, državna sekretarka Министарство науке, технолошког развоја и иновација, dr Marija Gnjatovic zaključila je da ovakav događaj predstavlja važan iskorak u definisanju zajedničke vizije između države i naučnih institucija jer održivi napredak nastaje tamo gde su znanje, partnerstva i sistemi međusobno usklađeni, a naučni rezultati imaju realnu putanju ka primeni. 🔬🤝🏛️

U svom obraćanju je apostrofirala da se savremeni izazovi mogu prevazići kada institucije preuzmu aktivnu ulogu u povezivanju znanja, ljudi i procesa, uz kapacitet da odgovore na naučne i društvene potrebe. Dr Gnjatović ističe:

„Institut za medicinska istraživanja ima potencijal i kapacitet da bude lider u biomedicinskim i biotehnološkim naukama i već pokazuje da je na tom putu”.

----

At the recent Forum, State Secretary at the Министарство науке, технолошког развоја и иновација, Dr. Marija Gnjatovic, noted that events like this mark an important step toward shaping a shared vision between government and scientific institutions, where sustainable progress emerges when knowledge, partnerships, and systems are aligned, and research results have a clear path to application. 🧬🤝🏛️

In her remarks, she emphasized that today’s complex challenges are best addressed when institutions take an active role in connecting knowledge, people, and processes, with the capacity to respond to both scientific and societal needs. Dr. Gnjatović added:

“The Institute for Medical Research has the potential and capacity to become a leader in biomedical and biotechnological sciences and is already demonstrating that it is on that path.”

Address

Dr Subotica 4
Belgrade
11000

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

+381112685179

Alerts

Be the first to know and let us send you an email when Институт за медицинска истраживања posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Институт за медицинска истраживања:

Share